GENKYOTEX
Summary
Genkyotex is the leading biopharmaceutical company in NOX therapies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 79 M
Avg. Deal Size£ 79 M
All rights reserved. Copyright © 2025 Datasite
Summary
Genkyotex is the leading biopharmaceutical company in NOX therapies.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Elias Papatheodorou
CEO
Alexandre Grassin
CFO
Claudio Nessi
Chairman